Dexamethasone Pediatric Dose — Asthma & Respiratory
Dexamethasone is a potent, long-acting corticosteroid that exerts anti-inflammatory effects by suppressing the release of inflammatory mediators and reducing airway edema. It is widely used in pediatric acute asthma exacerbations as a short-course alternative to traditional multi-day prednisone regimens. Its prolonged half-life allows for a simplified two-dose protocol, which has been shown to improve adherence and tolerability in children.
Pediatric Dosing
- Dose: 0.6 mg/kg per dose IV or PO
- Frequency: Two doses given 24 hours apart
- Maximum dose: 16 mg/dose
For a 20 kg child: 20 × 0.6 mg/kg = 12 mg per dose (two doses total, separated by 24 hours). For a 30 kg child: 30 × 0.6 mg/kg = 18 mg — capped at the maximum of 16 mg/dose.
Indications and Clinical Context
Dexamethasone is indicated for the management of acute asthma exacerbations in pediatric patients requiring systemic corticosteroid therapy. Corticosteroids are a cornerstone of asthma exacerbation treatment per PALS and GINA guidelines, acting to reduce airway inflammation and decrease the risk of relapse following an acute episode. The two-dose dexamethasone protocol has emerged as a preferred alternative to a 3–5 day prednisone course in many pediatric emergency and inpatient settings.
This regimen is appropriate across a range of exacerbation severities where systemic steroids are clinically indicated. Its oral bioavailability makes it suitable for both inpatient IV use and outpatient or ED-to-discharge PO administration, supporting continuity of care.
Administration and Monitoring
Dexamethasone may be administered intravenously or orally. The oral route is generally preferred when the patient can tolerate it, given equivalent bioavailability and the practical advantage of facilitating discharge with the second dose. When given IV, administer as a slow push or short infusion per institutional protocol. The second dose should be given approximately 24 hours after the first; if the patient is discharged, the second dose may be sent home with appropriate caregiver instructions.
- Confirm weight-based dose does not exceed 16 mg/dose
- Monitor for transient hyperglycemia, particularly in patients with diabetes or those receiving high-dose beta-agonists
- GI upset is less common with dexamethasone than with prednisone but may occur; administer with food if tolerated
- Use with caution in patients with active systemic infections; consult institutional protocol for specific contraindications
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.